| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7238 |
| Human Intestinal Absorption | HIA+ | 0.9909 |
| Caco-2 Permeability | Caco2+ | 0.5973 |
| P-glycoprotein Substrate | Non-substrate | 0.5995 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9873 |
| Non-inhibitor | 0.9780 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8117 |
| Distribution |
| Subcellular localization | Lysosome | 0.4640 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7576 |
| CYP450 2D6 Substrate | Substrate | 0.6680 |
| CYP450 3A4 Substrate | Non-substrate | 0.6885 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8197 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8768 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6530 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7186 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8335 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7702 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8963 |
| Non-inhibitor | 0.8964 |
| AMES Toxicity | Non AMES toxic | 0.7275 |
| Carcinogens | Non-carcinogens | 0.7634 |
| Fish Toxicity | High FHMT | 0.6706 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5834 |
| Honey Bee Toxicity | Low HBT | 0.5000 |
| Biodegradation | Not ready biodegradable | 0.9006 |
| Acute Oral Toxicity | II | 0.4955 |
| Carcinogenicity (Three-class) | Non-required | 0.6884 |